410 related articles for article (PubMed ID: 11517443)
1. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
2. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
[TBL] [Abstract][Full Text] [Related]
3. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
6. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
[TBL] [Abstract][Full Text] [Related]
7. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
[TBL] [Abstract][Full Text] [Related]
8. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
9. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.
Cooper D; Yu X; Sidhu M; Nahm MH; Fernsten P; Jansen KU
Vaccine; 2011 Sep; 29(41):7207-11. PubMed ID: 21689707
[TBL] [Abstract][Full Text] [Related]
10. Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal vaccination states.
Tarragó D; Aguilar L; Jansen WT; Giménez MJ; Avellón A; Granizo JJ; Casal J
Clin Microbiol Infect; 2007 Apr; 13(4):369-76. PubMed ID: 17359320
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
12. Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?
Väkeväinen M; Jansen W; Saeland E; Jonsdottir I; Snippe H; Verheul A; Käyhty H
Clin Diagn Lab Immunol; 2001 Mar; 8(2):363-9. PubMed ID: 11238223
[TBL] [Abstract][Full Text] [Related]
13. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
[TBL] [Abstract][Full Text] [Related]
14. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
Simell B; Nurkka A; Ekström N; Givon-Lavi N; Käyhty H; Dagan R
Clin Vaccine Immunol; 2012 Oct; 19(10):1618-23. PubMed ID: 22875604
[TBL] [Abstract][Full Text] [Related]
15. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
16. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
[TBL] [Abstract][Full Text] [Related]
17. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
[TBL] [Abstract][Full Text] [Related]
18. Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.
Wuorimaa TK; Dagan R; Bailleux F; Haikala R; Ekström N; Eskola J; Yaich M; Käyhty H
Vaccine; 2005 Nov; 23(46-47):5328-32. PubMed ID: 16118028
[TBL] [Abstract][Full Text] [Related]
19. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
Henckaerts I; Durant N; De Grave D; Schuerman L; Poolman J
Vaccine; 2007 Mar; 25(13):2518-27. PubMed ID: 17034907
[TBL] [Abstract][Full Text] [Related]
20. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
Jokinen JT; Ahman H; Kilpi TM; Mäkelä PH; Käyhty MH
J Infect Dis; 2004 Aug; 190(3):545-50. PubMed ID: 15243930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]